Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/7/14 → 11/18/16 |
Funding
- PSMA Development Company LLC: $18,512.50
An Open-label Treatment Extension of PSMA ADC in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Wu, Shenhong (PI)
- Kudelka, Andrzej (CoPI)
Project: Research